CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Grant or award EVP, Research & CSO acquired 30,000 shares (grant or award)
- 4 Exercise or conversion Chief Medical Officer acquired 10,000 shares (option exercise)
- 4 Grant or award Chief Administrative Officer acquired 20,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 111,000 shares (grant or award)
- 4 Exercise or conversion Chief Medical Officer acquired 10,000 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $71.16 ($562,161)
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $69.91 ($485,424)
- 4 Open-market sale EVP, Research & CSO sold 31,300 shares at $48.17 ($1,507,806)
- 4 Open-market sale EVP, Research & CSO sold 10,530 shares at $38.00 ($400,140)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $29.36 ($111,696)
- 4 Open-market sale Chief Business Officer sold 6,945 shares at $26.32 ($182,795)
- 4 Exercise or conversion EVP, Research & CSO acquired 9,500 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.19 ($118,683)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.27 ($118,966)
- 4 Open-market sale Chief Business Officer sold 6,945 shares at $31.53 ($218,968)
- 4 Exercise or conversion Chief Medical Officer acquired 7,500 shares (option exercise)
Page 19 of 25 · 491 filings